Global Needle-Free Drug Delivery Market 2017-2021

  • ID: 4312798
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • CROSSJECT
  • European Pharma Group
  • PenJet Corporation
  • Valeritas
  • MORE
Needle free drug delivery technologies are used to deliver biologics such as insulin, vaccines, human growth hormone (HGH), and drugs for pain management into the patient’s body without using a traditional needle. Needle free drug delivery market includes jet injectors, transdermal drug delivery systems and other novel needle free devices that are used as alternatives to conventional needle drug delivery devices.

The report forecasts that the global needle free drug delivery market to grow at a CAGR of 10.31% during the period 2017-2021.

Covered in this report:

The report covers the present scenario and the growth prospects of the global needle free drug delivery market for 2017-2021. To calculate the market size, the report considers sales and value.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
This report, Global Needle Free Drug Delivery Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion operating in this market.

Key vendors:
  • Endo Pharmaceuticals
  • Antares Pharma
  • Inovio Pharmaceuticals
  • Valeritas
  • PharmaJet
Other prominent vendors:
  • 3M
  • Akra Dermojet
  • Consort Medical
  • CROSSJECT
  • Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
  • PenJet Corporation
  • Zosano
  • D’Antonio Consultants International
  • European Pharma Group
Market drivers:
  • Increasing incidence of needle stick injuries
  • For a full, detailed list, view this report
Market challenges:
  • Technical complexities of needle free drug delivery devices
  • For a full, detailed list, view this report
Market trends:
  • Increasing outsourcing
  • For a full, detailed list, view this report
Key questions answered in this report:
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • CROSSJECT
  • European Pharma Group
  • PenJet Corporation
  • Valeritas
  • MORE
Part 01: Executive summary

Part 02: Scope of the report

Part 03: Research Methodology

Part 04: Introduction
  • Market outline
Part 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
Part 06: Market segmentation by product/technology
  • Jet injectors
  • Market size and forecast
  • Transdermal drug delivery systems
  • Market size and forecast
  • Others
  • Market size and forecast
Part 07: Market segmentation by application
  • Market segmentation by application
  • Insulin delivery
  • Vaccination
  • Pain management
  • Others
Part 08: Geographical segmentation
  • Market overview
  • Americas
  • EMEA
  • APAC
Part 09: Decision framework

Part 10: Drivers and challenges
  • Market drivers
  • Market challenges
Part 11: Market trends
  • Technological innovations
  • Increasing outsourcing
  • M&A and strategic collaborations
Part 12: Vendor landscape
  • Competitive scenario
Part 13: Key vendor analysis
  • Endo Pharmaceuticals
  • Antares Pharma
  • Inovio Pharmaceuticals
  • Valeritas
  • PharmaJet
  • Other prominent vendors
Part 14: Appendix

List of abbreviations

List of Exhibits
Exhibit 01: Global needle free drug delivery market: Segmentation overview
Exhibit 02: Global needle free drug delivery market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global needle free drug delivery market by product/technology
Exhibit 05: Global needle free drug delivery market share by product/technology 2016 (%)
Exhibit 06: Jet injectors in market
Exhibit 07: Jet injectors in development
Exhibit 08: Global jet injectors market 2016-2021: Overview
Exhibit 09: Global jet injectors market 2016-2021 ($ billions)
Exhibit 10: Microneedle drug delivery systems in market
Exhibit 11: Microneedle drug delivery systems in development
Exhibit 12: Iontophoresis drug delivery systems in market
Exhibit 13: Global transdermal drug delivery systems market 2016-2021: Overview
Exhibit 14: Global transdermal needle free drug delivery systems market 2016-2021 ($ billions)
Exhibit 15: Other drug delivery systems in market
Exhibit 16: Global other needle free drug delivery devices market 2016-2021 ($ billions)
Exhibit 17: Global needle free drug delivery market by application
Exhibit 18: Global needle free drug delivery market share by application 2016 (%)
Exhibit 19: Needle free insulin delivery systems in market
Exhibit 20: Needle free insulin delivery systems in development
Exhibit 21: Needle free vaccine delivery systems in market
Exhibit 22: Needle free vaccine delivery systems in development
Exhibit 23: Global needle free drug delivery market by geography 2016 (%)
Exhibit 24: Needle free drug delivery market in Americas 2016-2021 ($ billions)
Exhibit 25: Needle free drug delivery market in EMEA 2016-2021 ($ billions)
Exhibit 26: Needle free drug delivery market in APAC 2016-2021 ($ billions)
Exhibit 27: Endo International: Key highlights
Exhibit 28: Endo International: Strength assessment
Exhibit 29: Endo International: Strategy assessment
Exhibit 30: Endo International: Opportunity assessment
Exhibit 31: Antares Pharma: Key highlights
Exhibit 32: Antares Pharma: Strength assessment
Exhibit 33: Antares Pharma: Strategy assessment
Exhibit 34: Antares Pharma: Opportunity assessment
Exhibit 35: Inovio Pharmaceuticals: Key highlights
Exhibit 36: Inovio Pharmaceuticals: Strength assessment
Exhibit 37: Inovio Pharmaceuticals: Strategy assessment
Exhibit 38: Inovio Pharmaceuticals: Opportunity assessment
Exhibit 39: Valeritas: Key highlights
Exhibit 40: Valeritas: Strength assessment
Exhibit 41: Valeritas: Strategy assessment
Exhibit 42: Valeritas: Opportunity assessment
Exhibit 43: PharmaJet: Key highlights
Exhibit 44: PharmaJet: Strength assessment
Exhibit 45: PharmaJet: Strategy assessment
Exhibit 46: PharmaJet: Opportunity assessment
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • 3M
  • Antares Pharma
  • CROSSJECT
  • European Pharma Group
  • PenJet Corporation
  • Valeritas
  • MORE
New Research Report - Global Needle-Free Drug Delivery Market 2017-2021

Other Prominent Vendors in the market are: 3M, Akra Dermojet, Consort Medical, CROSSJECT, Injex Pharma (acquired by Hangzhou Hema Medical Equipment), PenJet Corporation, Zosano, D’Antonio Consultants International, and European Pharma Group.

Commenting on the report, an analyst from the research team said: “One trend in the market is increasing outsourcing. Companies are outsourcing secondary processes such as manufacturing, logistics, and sterilization to third parties to cut down costs and focus on improving their core product offerings. Many companies such as PharmaJet and Antares Pharma have outsourced their manufacturing operations to third parties.”

According to the report, one driver in the market is increasing incidence of needle stick injuries. According to CDC estimates 12 billion injections are administered annually worldwide. Unsafe injections are resulting in large proportion of bloodborne disease transmission. The percentage of unsafe injections range from 15% in Eastern Europe to 50% in Asia. The contaminated and unsafe needle injections are causing millions of deaths and disability-adjusted life years in healthcare settings.

Further, the report states that one challenge in the market is technical complexities of needle free drug delivery devices. Operating first-generation needle free systems is a complex process compared with standard needle-based systems. The patients must load the spring or prepare the gas reservoir before filling the drug into the cartridge in the autoinjector. Hence, users might need to undergo a moderate level of training, which can be time-consuming.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • Endo Pharmaceuticals
  • Antares Pharma
  • Inovio Pharmaceuticals
  • Valeritas
  • PharmaJet
  • 3M
  • Akra Dermojet
  • Consort Medical
  • CROSSJECT
  • Injex Pharma (acquired by Hangzhou Hema Medical Equipment)
  • PenJet Corporation
  • Zosano
  • D’Antonio Consultants International
  • European Pharma Group
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll